Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Fig. 1

ERCC6L expression in upregulated in HCC. a Representative pictures of IHC staining on the tissue chip of HCC for ERCC6L. b Chi-square analysis of ERCC6L expression according to the IHC results in HCC tumor and adjacent non-tumor tissue. c Paired HCC tissue IHC scores for 90 patients (tumor versus adjacent non-tumor). d Overall survival of HCC patients with different levels of ERCC6L expression. e. ERCC6L mRNA expression in Hep3B, HuH-7, and SMMC-7721 cells compared to HL-7702 cells, *p < 0.05. All of the expression levels were normalized to β-actin levels. All experiments were carried out at least three independent times

Back to article page